feed,title,long_url,short_url
Benzinga,"IDEAYA Advances IDE161 Into IND-Enabling Studies, Exercises Licensing Option For PARG Inhibitors",https://benzinga.com/general/biotech/22/01/25302979/ideaya-advances-ide161-into-ind-enabling-studies-exercises-licensing-option-for-parg-inhibitors,https://bit.ly/3ubzucP
